Please assess the completion status of the following clinical trial:

Trial Title: Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Informed Consent as documented by signature~* Age ≥40 years~* History of ≥10 pack-years of smoking (past or present smokers)~* Airway obstruction, defined as FEV1/FVC≤70%~* Current acute exacerbation of COPD by clinical criteria, defined by the presence of at least two of the following:~  * Change of baseline dyspnea~ * Change of cough~ * Change of sputum quantity or purulence~Exclusion Criteria:~* Diagnosis of asthma~* Initial necessity of hospitalization~* Women who are pregnant or breast feeding~* Premenopausal women with insufficient contraception and anamnestic risk for pregnancy~* Severe coexisting disease with life expectancy \<6 months~* Diagnosis of tuberculosis~* Known severe immunosuppression or immunosuppression after solid organ or stem cell transplantation~* Inability to follow study procedures, e.g. due to language problems, psychological disorders, dementia, etc. of the participant~* Participation in another study involving an investigational drug~* Previous enrolment into the current study

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Investigational treatment (Type: EXPERIMENTAL): Patients included in the placebo group are receiving systemic corticosteroid treatment (equivalent of 40mg prednisone daily) for three days followed by two days of placebo.
- Standard treatment (Type: ACTIVE_COMPARATOR): Patients included in the control group are receiving systemic corticosteroid treatment (equivalent of 40mg prednisone daily) for five days as recommended in current guidelines.

Based on this trial design, predict the completion outcome and termination type (if applicable).